VANCOUVER, British Columbia , Jan. 03, 2024 – Anfield Energy Inc. (TSX.V: AEC; OTCQB: ANLDF; FRANKFURT: 0AD) (“Anfield” or “the Company”) is pleased to announce that its subsidiary, Highbury Resources, Inc. (“Highbury”) has entered into a definitive agreement...
VANCOUVER, British Columbia, Dec. 22, 2023 – Anfield Energy Inc. (TSX.V: AEC; OTCQB: ANLDF; FRANKFURT: 0AD) (“Anfield” or “the Company”) is pleased to announce that it has closed its oversubscribed non-brokered private placement via the issuance of 47,726,100...
TORONTO, Dec. 18, 2023 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to...
Toronto, Ontario – December 13, 2023 – PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLD) (“PharmaDrug” or the “Company”), a specialty pharmaceutical company focused on the research, development and commercialization of...
VANCOUVER, British Columbia, Dec. 07, 2023 – Anfield Energy Inc. (TSX.V: AEC; OTCQB: ANLDF; FRANKFURT: 0AD) (“Anfield” or “the Company”) is pleased to announce that it will conduct a non-brokered private placement for up to 40,000,000 Units at a price of $0.065...
TORONTO, Nov. 21, 2023 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, provides an...
